108 related articles for article (PubMed ID: 2252150)
1. [Gynecologic cytological cancer screening over an 11-year period].
Kasabova M; Ganchev I
Akush Ginekol (Sofiia); 1990; 29(3):55-9. PubMed ID: 2252150
[TBL] [Abstract][Full Text] [Related]
2. [Colposcopy and cytologic examination in large-scale prophylactic examination of women].
Piperkov T
Akush Ginekol (Sofiia); 1971; 10(2):136-40. PubMed ID: 5563201
[No Abstract] [Full Text] [Related]
3. [The role of colposcopy in evaluation of the cervix for unexpectedly positive pap smears].
Jesień-Sokołowska U; Madej JG
Przegl Lek; 1999; 56(1):17-9. PubMed ID: 10375918
[TBL] [Abstract][Full Text] [Related]
4. Optimum screening interventions for gynecologic malignancies.
Lea JS; Miller DS
Tex Med; 2001 Feb; 97(2):49-55. PubMed ID: 11233059
[TBL] [Abstract][Full Text] [Related]
5. [Organization of prophylactic gynecologic exams with mass cytological screening of women].
Buval'tseva NA; Kvashenko BK
Pediatr Akus Ginekol; 1978; (3):35-6. PubMed ID: 673514
[No Abstract] [Full Text] [Related]
6. [Counseling protocol for early cancer detection at the Women's Health Center in Ruma].
Nedić B; Ravić J; Loncar S; Cuk D
Med Pregl; 1999; 52(3-5):162-4. PubMed ID: 10518403
[TBL] [Abstract][Full Text] [Related]
7. Screening for gynecologic cancer.
Pretorius G
Surg Oncol Clin N Am; 1998 Apr; 7(2):263-9. PubMed ID: 9537975
[TBL] [Abstract][Full Text] [Related]
8. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
10. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.
Linder J; Zahniser D
Arch Pathol Lab Med; 1998 Feb; 122(2):139-44. PubMed ID: 9499356
[TBL] [Abstract][Full Text] [Related]
11. [False negative Pap smears in a Danish material].
Ejersbo D; Dahl MB; Hølund B
Ugeskr Laeger; 2003 Jun; 165(23):2391-4. PubMed ID: 12840998
[TBL] [Abstract][Full Text] [Related]
12. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
[TBL] [Abstract][Full Text] [Related]
13. Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer?
Cooper AL; Dornfeld-Finke JM; Banks HW; Davey DD; Modesitt SC
Obstet Gynecol; 2006 Jan; 107(1):71-6. PubMed ID: 16394042
[TBL] [Abstract][Full Text] [Related]
14. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
15. [Integrating HPV testing for primary screening?].
Riethmuller D; Ramanah R; Pretet JL; Mougin C
J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S139-51. PubMed ID: 18191912
[TBL] [Abstract][Full Text] [Related]
16. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
17. [Statistical evaluation of the diagnostic effectiveness of cytological and clinical methods in the mass prevention of female genital tumors].
Gualandri V; Galeazzi L
Minerva Ginecol; 1971 Feb; 23(3):148-50. PubMed ID: 5579733
[No Abstract] [Full Text] [Related]
18. The diagnostic value of computer-assisted primary cervical smear screening: a longitudinal cohort study.
Doornewaard H; van der Schouw YT; van der Graaf Y; Bos AB; Habbema JD; van den Tweel JG
Mod Pathol; 1999 Nov; 12(11):995-1000. PubMed ID: 10574595
[TBL] [Abstract][Full Text] [Related]
19. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
[TBL] [Abstract][Full Text] [Related]
20. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
